pub med big

Anticancer mechanisms of cannabinoids.

  Journal List > Curr Oncol > v.23(Suppl 2); 2016 Mar > PMC4791144 Curr Oncol. 2016 Mar; 23(Suppl 2): S23–S32.  Published online 2016 Mar 16. doi:  10.3747/co.23.3080 PMCID: PMC4791144 Anticancer mechanisms of cannabinoids G. Velasco, PhD,*†‡ C. Sánchez, PhD,*§ and  M. Guzmán, PhD*†‖ Author information ► Copyright and License information ► Go to: Abstract In addition to the well-known palliative effects of cannabinoids on some cancer-associated symptoms, a large body […]

PM 2 site 207

The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.

CNS Drugs. 2019 Apr 11. doi: 10.1007/s40263-019-00627-1. [Epub ahead of print] Artukoglu BB1, Bloch MH2. Author information Abstract Novel pharmacological treatments are needed for Tourette syndrome. Our goal was to examine the current evidence base and biological rationale for the use of cannabis-derived medications or medications that act on the cannabinoid system in Tourette syndrome. […]

PM 2 site 207

[Significance of the endocannabinoid system in migraine].

Neuropsychopharmacol Hung. 2019 Mar;21(1):12-18. [Article in Hungarian] Gecse K1, Bagdy G, Juhasz G. Author information Abstract Based on the traditional pain-relieving effect of Cannabis species an endogenous cannabinoid like system was discovered in the human body. Endocannabinoids have important role in the homeostasis of the body, such as stress response and mood control, feeding behaviour, […]

PM 2 site 207

Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions.

Neuropharmacology. 2019 Apr 10. pii: S0028-3908(19)30121-2. doi: 10.1016/j.neuropharm.2019.04.010. [Epub ahead of print] Nguyen JD1, Grant Y1, Creehan KM1, Hwang CS2, Vandewater SA3, Janda KD4, Cole M5, Taffe MA6. Author information Abstract Growing nonmedical use of prescription opioids is a global problem, motivating research on ways to reduce use and combat addiction. Medical cannabis (“medical marijuana”) […]

PM 2 site 207

Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.

Psychopharmacology (Berl). 2019 Apr 9. doi: 10.1007/s00213-019-05238-8. [Epub ahead of print] Mensen VT1, Vreeker A2, Nordgren J3, Atkinson A4, de la Torre R5, Farré M5,6, Ramaekers JG7, Brunt TM8,9. Author information Abstract BACKGROUND: Synthetic cannabinoids (SCs) are a class of new psychoactive substances that have been rapidly evolving around the world throughout recent years. Many […]

PM 2 site 207

Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD.

Biol Psychol. 2019 Apr 9. pii: S0301-0511(19)30011-0. doi: 10.1016/j.biopsycho.2019.04.002. [Epub ahead of print] Crombie KM1, Leitzelar BN2, Brellenthin AG3, Hillard CJ4, Koltyn KF2. Author information Abstract The endocannabinoid (eCB) system is a modulatory system that is both altered by stress and mediates the effects of acute stress, including contributing to restoration of homeostasis. Earlier studies […]

PM 2 site 207

Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder.

Med Sci Sports Exerc. 2019 Apr 8. doi: 10.1249/MSS.0000000000002006. \[Epub ahead of print] Meyer JD1, Crombie KM2, Cook DB2,3, Hillard CJ4, Koltyn KF2. Author information Abstract The endocannabinoid (eCB) system is implicated in the pathophysiology of depression and is responsive to acute exercise in healthy adults. PURPOSE: We aimed to describe acute changes in serum […]

springer-logo-fw-site

Cannabis-based medicines

The pain April 2019 , Volume 33, Issue 2 , pp 97-99 | Cite as Expert consensus against systematic reviews? Authors Authors and affiliations M. enamel W. houses E. High F. Petzke C. summer Editorial First Online: 04 April 2019 75downloads Cannabis-based drugs Do not pit clinical experience and systematic reviews against each other You […]

PM 2 site 207

Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology.

Molecules. 2019 Apr 5;24(7). pii: E1350. doi: 10.3390/molecules24071350. Rodrigues RS1,2, Lourenço DM3,4, Paulo SL5,6, Mateus JM7,8, Ferreira MF9,10, Mouro FM11,12, Moreira JB13,14, Ribeiro FF15,16, Sebastião AM17,18, Xapelli S19,20. Author information Abstract With the increase of life expectancy, neurodegenerative disorders are becoming not only a health but also a social burden worldwide. However, due to the […]

The BMJ

Medicinal use of cannabis based products and cannabinoids

Practice Clinical Update BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l1141 (Published 04 April 2019)Cite this as: BMJ 2019;365:l1141 Article > Related content > Metrics > Responses Tom P Freeman, senior lecturer1 2 3 4, Chandni Hindocha, research fellow3 4 5, Sebastian F Green, academic foundation doctor4, Michael A P Bloomfield, UCL excellence fellow and, consultant psychiatrist3 4 5 6 7 […]

PM 2 site 207

Nutritional Value of Commercial Protein-Rich Plant Products.

Plant Foods Hum Nutr. 2018 Jun;73(2):108-115. doi: 10.1007/s11130-018-0660-7. Mattila P1, Mäkinen S2, Eurola M2, Jalava T2, Pihlava JM2, Hellström J2, Pihlanto A2. Author information Abstract The goal of this work was to analyze nutritional value of various minimally processed commercial products of plant protein sources such as faba bean (Vicia faba), lupin (Lupinus angustifolius), rapeseed […]